Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital | Scientific Reports
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Chapter 5.1 Recommended dosages of TPT medication | TB Knowledge Sharing
Latent Tuberculosis (LTBI) Treatment Flowsheet: Dose, Symptom Monitoring, Completion
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Rifapentine Dosing for Children With Latent Tuberculosis Infection in... | Download Table
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan - ScienceDirect
Latent Tuberculosis Infection (LTBI) Treatments
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection | NEJM
3HP for Latent TB Infection Treatment | CDC
Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 - Sterling - 2020 - American Journal of Transplantation - Wiley Online Library
Dosing regimens for tuberculosis | Download Table
1.4. Tuberculosis preventive treatment options | TB Knowledge Sharing
Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society
Treatment of Latent TB Infection | RheumNow
Treatment of latent tuberculosis infection | Semantic Scholar
Treatment for Latent TB Infection in Adults | Download Table
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society
Tuberculosis Series: Treatment - EthnoMed
CDC Recommends New Treatment Regimen for Latent Mycobacterium Tuberculosis Infection | AAFP
Frontiers | Diagnosis for Latent Tuberculosis Infection: New Alternatives
Identification and Management of Latent Tuberculosis Infection | AAFP
